Skip to content

Construction and evaluation of the full-process management model for preventive medication of venous thromboembolism after orthopedic trauma by clinical pharmacists

Construction and evaluation of the full-process management model for preventive medication of venous thromboembolism after orthopedic trauma by clinical pharmacists

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107932
Enrollment
Unknown
Registered
2025-08-21
Start date
2024-09-13
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism occurred after orthopedic trauma surgery

Interventions

Intervention group:The full-process management of VTE prevention by clinical pharmacists combined with regular medical care services
Control group:Conventional medical care services

Sponsors

Nanping First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Hip fractures (fractures of the hip, pelvis and acetabulum) and femoral shaft fractures Surgical patient; 2.Aged between 18 and 75; 3.Has signed informed consent and can cooperate to complete the follow-up.

Exclusion criteria

Exclusion criteria: 1.Patients with pathological fractures or those with fractures in other parts of the body, or those with multiple injuries; 2.Those with coagulation disorders, or those who have had active bleeding recently, or those with concurrent hemorrhagic diseases, or those with concurrent hematopoietic system diseases; 3.Pregnant women, lactating women, patients with mental disorders, and those with tumors; 4.Osteofascial compartment syndrome, rheumatoid retinopathy; 5.Severe head trauma, acute intracranial injury or acute spinal cord injury; 6.Creatinine clearance rate < 30 mL·min-1; 7.Those who are allergic to the drugs used in this study.

Design outcomes

Primary

MeasureTime frame
The incidence of venous thromboembolism;

Secondary

MeasureTime frame
Incidence of adverse events;Medication compliance;

Countries

China

Contacts

Public ContactRuping Ni

Nanping First Hospital

810838238@qq.com+86 599 8608039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026